The leukotriene B4 receptor antagonist ONO-4057 inhibits mesangioproliferative changes in anti-Thy-1 nephritis
Open Access
- 11 October 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 20 (12) , 2697-2703
Abstract
Objective. ONO-4057 is a specific leukotriene B4 (LTB4) receptor antagonist which inhibits human neutrophil aggregation, chemotaxis and degranulation induced by LTB4. This study was conducted to evaluate the role of LTB4 in glomerulonephritis, and to examine whether ONO-4057 moderated anti-Thy-1 nephritis. Methods. Experiment 1: Sixty Wistar rats were divided into three groups. Rats of Group A (n = 20) underwent intraperitoneal administration of placebo as a control group, rats of Group B (n = 20) first underwent intraperitoneal administration of 100 mg/kg ONO-4057 and rats of Group C (n = 20) first underwent intraperitoneal administration of 300 mg/kg ONO-4057 daily from day 3 before anti-Thy-1 antibody (OX7) injection to day 14 after OX7 injection, respectively. Experiment 2: Forty rats were divided into two groups. ONO-group (n = 20) was treated with 300 mg/kg BW of ONO-4057 and placebo-group (n = 20) with placebo daily from days 1 to 13 after OX7 injection. Urine and blood samples were collected and the kidneys were extirpated from five rats of each group sacrificed at 3 h, 24 h, day 7 or day 14 after the injection of OX7 in both experiments. Urinary protein excretion, renal function and pathological findings were analysed in each group of both experiments. Results. (1) Glomerular infiltration by polymorphonuclear leucocytes (PMNs) and macrophages at 3 h was less in Groups B and C than in Group A, and matrix scores at day 7 were lower in Groups B and C than in Group A. Injury scores did not differ among the groups. (2) Urinary protein excretion at day 7 was less in Group C than in Group A. (3) Neither pathological findings nor urinary protein excretion differed between ONO-group and placebo-group. Conclusion. These results suggest that LTB4 is associated not with the pathogenesis of complement-dependent mesangial cell lysis but with that of mesangial proliferative change in anti-Thy-1 nephritis.Keywords
This publication has 15 references indexed in Scilit:
- Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2Journal of Biological Chemistry, 2005
- C5a-Mediated Leukotriene B4-Amplified Neutrophil Chemotaxis Is Essential in Tumor Immunotherapy Facilitated by Anti-Tumor Monoclonal Antibody and β-GlucanThe Journal of Immunology, 2005
- Leukotriene B4: Metabolism and Signal TransductionArchives of Biochemistry and Biophysics, 2001
- Characterization of complement C6 deficiency in a PVG/c rat strainClinical and Experimental Immunology, 1997
- Induction of microhematuria by an IgA isotype switch variant of a monoclonal anti-Thy-1.1 antibody in the ratKidney International, 1996
- Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritisKidney International, 1996
- Apoptosis of cultured rat glomerular mesangial cells induced by IgG2a monoclonal anti-Thy-1 antibodiesKidney International, 1996
- Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injuryKidney International, 1992
- Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids.Journal of Clinical Investigation, 1991
- Quantitative and qualitative studies of antibody–induced mesangial cell damage in the ratKidney International, 1987